Eli Lilly’s Weight-Loss Pill Wins FDA Approval
The Business of Fashion
April 1, 2026
Orforglipron, which will be sold under the brand name Foundayo, becomes the second GLP-1 weight-loss pill to enter the US market after Novo Nordisk’s tablet-form Wegovy launched in Jan. 2026.
Discussion in the ATmosphere